Company: LRHC
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112656
Chunk: 211

Company: La Rosa Holdings Corp.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 8
Chunk 211
---
. On September 29, 2025, the Company filed a definitive information statement on Schedule 14C with the SEC and commenced
mailing of the definitive information statement to stockholders of record on September 19, 2025. Such stockholders’ approval became
effective on October 19, 2025. In accordance with the terms of the Amended RRA, on September 25, 2025, the Company filed with the SEC
a Registration Statement on Form S-1 (Reg. No. 333-290510) to register up to 283,333,333 shares of common stock issuable pursuant to the
Amended Facility Agreement. Such registration statement, as amended, was declared effective by the SEC on September 30, 2025.

43

February 2025 Financing and June 2025
Exchange Agreement

On
February 4, 2025 (“Closing Date”), the Company entered into the SPA with an institutional investor (“2025 Investor”)
pursuant to which it agreed to issue and sell to the 2025 Investor upon the terms and conditions set forth in the SPA on such date:
(i) a Senior Secured Convertible Note in the original principal amount of $5,500,000 which matures on the two-year anniversary of the
Closing Date (the “Initial Note”); and (ii) sixteen (16) warrants (the “Incremental Warrants”), each to purchase
additional Notes in an original principal amount up to $2,500,000 at an exercise price of $2,256,250, in substantially the same form
as the Initial Note (Incremental Notes and together with the Initial Note, the “Notes”). The Incremental Warrants and Initial
Note were issued to 2025 Investor on the Closing Date. The purchase price paid by 2025 Investor under the SPA for the Initial Note and
Incremental Warrants was $4,963,750, which was used by the Company to pay-off certain indebtedness, pay certain outstanding fees and
expenses, acquisitions and general corporate purposes. The Company also granted 2025 Investor registration rights in the shares of common
stock issuable pursuant to the SPA and conversion of the Notes. The Company and its subsidiaries also entered into a security agreement
with or in favor of the 2025 Investor pursuant to which the Company and its subsidiaries granted the 2025 Investor a security interest
in certain property of the Company and its subsidiaries to secure the Company’s obligations under